A comprehensive view of non-vaccine biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Denmark: AGC Biologics completes work with Var2 Pharmaceuticals
Published: April 24, 2024 by M-Brain Nordic News
AGC Biologics Announces Successful Completion of Production of Cancer-Specific Therapeutic Antibody Fragments with Var2 Pharmaceuticals
Published: April 24, 2024 by News Direct
Merck to acquire the University at Buffalo startup Abceutics for up to US$280.0M in a bid to enhance its antibody-drug conjugate pipeline; Abceutics is developing technology aimed at reducing the impact of therapies on healthy cells
Published: April 08, 2024 by FierceBiotech
FDA approves J&J’s CARVYKTI to treat patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy; an estimated 35,000 cases of the disease projected to be diagnosed this year in US
Published: April 06, 2024 by Janssen Pharmaceutical Companies
Becker's Hospital Review Underscores Industry Shifts with Vaccine Updates, Strikes, Legal Battles, Financial Challenges, Work-Life Reforms, Cyber Responses, and Pricing Scrutiny
Published: March 07, 2024 by Industry Intelligence Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count